Nadia Harbeck

4 ta ish

Ludwig Maximilian University of Munich

1. Breast cancer

   Nadia Harbeck, Frédérique Penault‐Llorca, Javier Cortés +6

   Sharh maqolaOAOchiq kirish20193 iqtibos

   ABIABI:AkademIndex/2026.other.030550

2. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials

   Gϋnter von Minckwitz, Michael Untch, Eveline Nüesch +20

   Maqola20103 iqtibos

   ABIABI:AkademIndex/2026.other.434431

3. Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

   Elizabeth A. Mittendorf, Hong Zhang, Carlos H. Barrios +17

   MaqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.098778

4. Enhancing global access to cancer medicines

   Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13

   Sharh maqolaOAOchiq kirishEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians20201 iqtibos

   ABIABI:AkademIndex/2026.other.000031